These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15009322)

  • 41. Cyclosporine in treatment of progressive systemic sclerosis: clinical and immunologic findings.
    Ippoliti G; Miori L; Negri M; Rovati B; Lorenzutti F; Zerbinati N; Rabbiosi G
    Transplant Proc; 1994 Dec; 26(6):3117-8. PubMed ID: 7527949
    [No Abstract]   [Full Text] [Related]  

  • 42. Scleroderma treated with immunosuppressive drugs.
    Kurwa AR; Denman AM
    Br J Dermatol; 1979 Jul; 101 Suppl 17():56-7. PubMed ID: 313805
    [No Abstract]   [Full Text] [Related]  

  • 43. [Progressive scleroderma and dermatomyositis].
    Ricken D
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():751-6. PubMed ID: 77111
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of systemic cyclosporin A in a case of severe Toxocara uveitis.
    Mora P; Vecchi M; Barbera L; Toscani M; Orsoni JG
    J Infect; 2006 May; 52(5):e159-61. PubMed ID: 16213025
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of complications associated with systemic sclerosis.
    Moore SC; Desantis ER
    Am J Health Syst Pharm; 2008 Feb; 65(4):315-21. PubMed ID: 18238768
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Immunosuppression followed by autologous hematopoietic stem cell transplantation for the treatment of severe systemic lupus erythematosus, systemic sclerosis and rheumatoid arthritis].
    Giebel S; Zoń-Giebel A; Błach A; Kucharz EJ; Hołowiecki J
    Pol Arch Med Wewn; 2003 Aug; 110(2):891-7. PubMed ID: 14682229
    [No Abstract]   [Full Text] [Related]  

  • 47. Systemic sclerosis.
    Hughes M; Herrick A
    Br J Hosp Med (Lond); 2012 Sep; 73(9):509-10, 511-6. PubMed ID: 23124403
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are we too lenient with immunosuppression in severe cases of Systemic Sclerosis?
    Siegert E; Riemekasten G
    Rheumatology (Oxford); 2016 Oct; 55(10):1914-6. PubMed ID: 27330162
    [No Abstract]   [Full Text] [Related]  

  • 49. Targeting activated T cells: successful use of anti-CD25 monoclonal antibody basiliximab in a patient with systemic sclerosis.
    Scherer HU; Burmester GR; Riemekasten G
    Ann Rheum Dis; 2006 Sep; 65(9):1245-7. PubMed ID: 16905582
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment of systemic sclerosis (except pulmonary arterial hypertension)].
    Hachulla E
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S277-84. PubMed ID: 17977626
    [No Abstract]   [Full Text] [Related]  

  • 51. New treatments in scleroderma: the rheumatologic perspective.
    Righi A; Cerinic MM
    J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):431-2. PubMed ID: 12428830
    [No Abstract]   [Full Text] [Related]  

  • 52. [Evidence-based therapy of systemic sclerosis].
    Genth E
    Z Rheumatol; 2001 Dec; 60(6):464-8. PubMed ID: 11826742
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Polymyositis and systemic sclerosis symptoms as a clinical manifestation of a chronic graft versus host disease: a case report and literature review].
    Tuchocka-Piotrowska A; Puszczewicz M; Kołczewska A; Majewski D
    Pol Arch Med Wewn; 2006 Apr; 115(4):356-60. PubMed ID: 17078495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary ascites as the presenting feature of systemic lupus erythematosus: response to cyclosporin therapy.
    Hernández Pérez J; Fernández Fernández J; Sanz Moreno C; Garrancho JM; Botella J
    Nephrol Dial Transplant; 1995; 10(8):1451-3. PubMed ID: 8538943
    [No Abstract]   [Full Text] [Related]  

  • 55. Death due to pulmonary tuberculosis in progressive systemic sclerosis.
    Manz B; Noack-Wiemers F; Mittag M; Haustein UF; Nenoff P
    J Eur Acad Dermatol Venereol; 2002 Nov; 16(6):647-8. PubMed ID: 12482061
    [No Abstract]   [Full Text] [Related]  

  • 56. Cyclophosphamide in scleroderma lung disease.
    Sullivan KM; McSweeney PA; Nash RA
    N Engl J Med; 2006 Sep; 355(11):1173-4; author reply 1174. PubMed ID: 16977701
    [No Abstract]   [Full Text] [Related]  

  • 57. Immunosuppression with chlorambucil, versus placebo, for scleroderma. Results of a three-year, parallel, randomized, double-blind study.
    Furst DE; Clements PJ; Hillis S; Lachenbruch PA; Miller BL; Sterz MG; Paulus HE
    Arthritis Rheum; 1989 May; 32(5):584-93. PubMed ID: 2655606
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Progressive systemic sclerosis and renal transplantation: a contraindication to ciclosporin.
    Ruiz JC; Val F; de Francisco AL; de Bonis E; Zubimendi JA; Prieto M; Canga E; Arias M
    Nephron; 1991; 59(2):330-2. PubMed ID: 1956502
    [No Abstract]   [Full Text] [Related]  

  • 59. Successful long-term use of cyclosporin A in HIV-induced pityriasis lichenoides chronica.
    Griffiths JK
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):396-7. PubMed ID: 9704950
    [No Abstract]   [Full Text] [Related]  

  • 60. [Systemic sclerosis].
    Villiger PM
    Ther Umsch; 2008 May; 65(5):283-7. PubMed ID: 18622933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.